Gene | Uniprot | Gene Full Name | Protein Class | pLI | DSI v | DPI v |
---|---|---|---|---|---|---|
CDKN2B-AS1 | CDKN2B antisense RNA 1 | 0.491 | 0.769 | |||
CASC15 | cancer susceptibility 15 | 0.603 | 0.577 | |||
SOX2-OT | SOX2 overlapping transcript | 0.597 | 0.615 | |||
BDNF-AS | BDNF antisense RNA | 0.638 | 0.538 | |||
SYN2 | Q92777 | synapsin II | Cellular structure | 0.653 | 0.577 | |
SCN1A-AS1 | SCN1A and SCN9A antisense RNA 1 | 0.636 | 0.346 | |||
SEMA3B | Q13214 | semaphorin 3B | Signaling | 0.633 | 0.615 | |
ADAMTS9-AS2 | ADAMTS9 antisense RNA 2 | 0.656 | 0.462 | |||
MIR100HG | mir-100-let-7a-2-mir-125b-1 cluster host gene | 0.682 | 0.308 | |||
HLA-DRB9 | major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 | |||
LINC00461 | long intergenic non-protein coding RNA 461 | 0.736 | 0.423 | |||
LINC01234 | long intergenic non-protein coding RNA 1234 | 0.700 | 0.346 | |||
TEX41 | testis expressed 41 | 0.743 | 0.269 | |||
CSMD2 | Q7Z408 | CUB and Sushi multiple domains 2 | 0.695 | 0.269 | ||
TDRG1 | testis development related 1 | 0.722 | 0.231 | |||
LINC01122 | long intergenic non-protein coding RNA 1122 | 0.821 | 0.269 | |||
LINC00598 | long intergenic non-protein coding RNA 598 | 0.743 | 0.192 | |||
AQP4-AS1 | AQP4 antisense RNA 1 | 0.751 | 0.577 | |||
LIPC-AS1 | LIPC antisense RNA 1 | 0.839 | 0.154 | |||
SCHLAP1 | SWI/SNF complex antagonist associated with prostate cancer 1 | 0.751 | 0.192 | |||
HOXB-AS3 | HOXB cluster antisense RNA 3 | 0.751 | 0.308 | |||
BORCS7-ASMT | BORCS7-ASMT readthrough (NMD candidate) | 0.805 | 0.154 | |||
CCND2-AS1 | CCND2 antisense RNA 1 | 0.760 | 0.154 | |||
RMST | rhabdomyosarcoma 2 associated transcript | 0.769 | 0.385 | |||
SAMMSON | survival associated mitochondrial melanoma specific oncogenic non-coding RNA | 0.780 | 0.231 |